Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

Abroad (travel likely)Recruiting

Conditions

Diabetic Retinopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Jennifer Moorer) · jmoorer@uabmc.edu · 2053258674
Contact: Principal Investigator (Maria B Grant, MD)

Study leads

Maria B Grant, MD
Principal Investigator
University of Alabama at Birmingham

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Mountain View, United States

National Eye Institute Biorepository for Retinal Diseases

Age-Related Macular Degeneration · Diabetic Retinopathy · Von Hippel-Lindau Syndrome

Abroad (travel likely)Recruiting

Bethesda, United States

Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment

Age-Related Macular Degeneration (AMD) · Diabetic Retinopathy (DR) · Retinal Detachment

Abroad (travel likely)Recruiting

Roma, Italy

Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies

Diabetic Retinopathy · Retinal Vein Occlusion

Abroad (travel likely)Recruiting

Reims, France